DelNova to Advance ReViVox™, A Groundbreaking Rescue Drug to Reverse Botulinum Toxin Neuromodulator Complications
DelNova announces advances in the development of the First ever product to reverse complications arising from botulinum toxins, such as BOTOX®, Dysport®, XEOMIN®, and Jeuveau®, US patent and launch of STARTENGINE equity crowdfunding....